APO RESEARCH · REPORT
Neurostimulation Devices
Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.
Product & engineering
Understand the product.
Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.
Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.
Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.
Selected research
Industry Research
Neurostimulation Devices Industry Research Report 2026
Market perspective
Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.
Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.
Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.
Read the full market overview
Global Neurostimulation Devices key players include Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 40 percent.
In terms of product, Spinal Cord Stimulation (SCS) is the largest segment, with a share over 55%. And in terms of application, the largest application is Pain Management, followed by Parkinson’s Disease, Epilepsy, Urinary and Fecal Incontinence, etc.
Report Scope
This report quantifies the global Neurostimulation Devices market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neurostimulation Devices Market by Company
Medtronic
Boston Scientific
Abbott
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical
Neurostimulation Devices Segment by Type
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Other
Neurostimulation Devices Segment by Application
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other
Neurostimulation Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurostimulation Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurostimulation Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurostimulation Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Neurostimulation Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Neurostimulation Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Neurostimulation Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Spinal Cord Stimulation (SCS)
- Gastric Electric Stimulation (GES)
- Deep Brain Stimulation (DBS)
- Sacral Nerve Stimulation (SNS)
- Vagus Nerve Stimulation (VNS)
- Other
Applications
- Pain Management
- Parkinson’s Disease
- Urinary and Fecal Incontinence
- Epilepsy
- Gastroparesis
- Other
Companies covered
- Medtronic
- Boston Scientific
- Abbott
- LivaNova
- Nevro
- NeuroPace
- Beijing Pins
- Synapse Biomedical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Neurostimulation Devices Market Size (2021-2032)
- 2.2.2 Global Neurostimulation Devices Sales (2021-2032)
- 2.2.3 Global Neurostimulation Devices Market Average Price (2021-2032)
- 2.3 Neurostimulation Devices by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Spinal Cord Stimulation (SCS)
- 2.3.3 Gastric Electric Stimulation (GES)
- 2.3.4 Deep Brain Stimulation (DBS)
- 2.3.5 Sacral Nerve Stimulation (SNS)
- 2.3.6 Vagus Nerve Stimulation (VNS)
- 2.3.7 Other
- 2.4 Neurostimulation Devices by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pain Management
- 2.4.3 Parkinson’s Disease
- 2.4.4 Urinary and Fecal Incontinence
- 2.4.5 Epilepsy
- 2.4.6 Gastroparesis
- 2.4.7 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Neurostimulation Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Neurostimulation Devices Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Neurostimulation Devices Revenue of Manufacturers (2021-2026)
- 3.4 Global Neurostimulation Devices Average Price by Manufacturers (2021-2026)
- 3.5 Global Neurostimulation Devices Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Neurostimulation Devices, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Neurostimulation Devices, Product Type & Application
- 3.8 Global Manufacturers of Neurostimulation Devices, Established Date
- 3.9 Global Neurostimulation Devices Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Medtronic
- 4.1.1 Medtronic Company Information
- 4.1.2 Medtronic Business Overview
- 4.1.3 Medtronic Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Medtronic Neurostimulation Devices Product Portfolio
- 4.1.5 Medtronic Recent Developments
- 4.2 Boston Scientific
- 4.2.1 Boston Scientific Company Information
- 4.2.2 Boston Scientific Business Overview
- 4.2.3 Boston Scientific Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Boston Scientific Neurostimulation Devices Product Portfolio
- 4.2.5 Boston Scientific Recent Developments
- 4.3 Abbott
- 4.3.1 Abbott Company Information
- 4.3.2 Abbott Business Overview
- 4.3.3 Abbott Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Abbott Neurostimulation Devices Product Portfolio
- 4.3.5 Abbott Recent Developments
- 4.4 LivaNova
- 4.4.1 LivaNova Company Information
- 4.4.2 LivaNova Business Overview
- 4.4.3 LivaNova Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 LivaNova Neurostimulation Devices Product Portfolio
- 4.4.5 LivaNova Recent Developments
- 4.5 Nevro
- 4.5.1 Nevro Company Information
- 4.5.2 Nevro Business Overview
- 4.5.3 Nevro Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Nevro Neurostimulation Devices Product Portfolio
- 4.5.5 Nevro Recent Developments
- 4.6 NeuroPace
- 4.6.1 NeuroPace Company Information
- 4.6.2 NeuroPace Business Overview
- 4.6.3 NeuroPace Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 NeuroPace Neurostimulation Devices Product Portfolio
- 4.6.5 NeuroPace Recent Developments
- 4.7 Beijing Pins
- 4.7.1 Beijing Pins Company Information
- 4.7.2 Beijing Pins Business Overview
- 4.7.3 Beijing Pins Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Beijing Pins Neurostimulation Devices Product Portfolio
- 4.7.5 Beijing Pins Recent Developments
- 4.8 Synapse Biomedical
- 4.8.1 Synapse Biomedical Company Information
- 4.8.2 Synapse Biomedical Business Overview
- 4.8.3 Synapse Biomedical Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Synapse Biomedical Neurostimulation Devices Product Portfolio
- 4.8.5 Synapse Biomedical Recent Developments
5 Global Neurostimulation Devices Market Scenario by Region
- 5.1 Global Neurostimulation Devices Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Neurostimulation Devices Sales by Region: 2021-2032
- 5.2.1 Global Neurostimulation Devices Sales by Region: 2021-2026
- 5.2.2 Global Neurostimulation Devices Sales by Region: 2027-2032
- 5.3 Global Neurostimulation Devices Revenue by Region: 2021-2032
- 5.3.1 Global Neurostimulation Devices Revenue by Region: 2021-2026
- 5.3.2 Global Neurostimulation Devices Revenue by Region: 2027-2032
- 5.4 North America Neurostimulation Devices Market Facts & Figures by Country
- 5.4.1 North America Neurostimulation Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Neurostimulation Devices Sales by Country (2021-2032)
- 5.4.3 North America Neurostimulation Devices Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Neurostimulation Devices Market Facts & Figures by Country
- 5.5.1 Europe Neurostimulation Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Neurostimulation Devices Sales by Country (2021-2032)
- 5.5.3 Europe Neurostimulation Devices Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Neurostimulation Devices Market Facts & Figures by Country
- 5.6.1 Asia Pacific Neurostimulation Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Neurostimulation Devices Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Neurostimulation Devices Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Neurostimulation Devices Market Facts & Figures by Country
- 5.7.1 South America Neurostimulation Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Neurostimulation Devices Sales by Country (2021-2032)
- 5.7.3 South America Neurostimulation Devices Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Neurostimulation Devices Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Neurostimulation Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Neurostimulation Devices Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Neurostimulation Devices Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Neurostimulation Devices Sales by Type (2021-2032)
- 6.1.1 Global Neurostimulation Devices Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Neurostimulation Devices Sales Market Share by Type (2021-2032)
- 6.2 Global Neurostimulation Devices Revenue by Type (2021-2032)
- 6.2.1 Global Neurostimulation Devices Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Neurostimulation Devices Revenue Market Share by Type (2021-2032)
- 6.3 Global Neurostimulation Devices Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Neurostimulation Devices Sales by Application (2021-2032)
- 7.1.1 Global Neurostimulation Devices Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Neurostimulation Devices Sales Market Share by Application (2021-2032)
- 7.2 Global Neurostimulation Devices Revenue by Application (2021-2032)
- 7.2.1 Global Neurostimulation Devices Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Neurostimulation Devices Revenue Market Share by Application (2021-2032)
- 7.3 Global Neurostimulation Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Neurostimulation Devices Value Chain Analysis
- 8.1.1 Neurostimulation Devices Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Neurostimulation Devices Production Mode & Process
- 8.2 Neurostimulation Devices Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Neurostimulation Devices Distributors
- 8.2.3 Neurostimulation Devices Customers
9 Global Neurostimulation Devices Analyzing Market Dynamics
- 9.1 Neurostimulation Devices Industry Trends
- 9.2 Neurostimulation Devices Industry Drivers
- 9.3 Neurostimulation Devices Industry Opportunities and Challenges
- 9.4 Neurostimulation Devices Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst